Source: Health Products Regulatory Authority (IE) Revision Year: 2022 Publisher: Mercury Pharmaceuticals (Ireland) Ltd, 4045 Kingswood Road, Citywest Business Park, Co Dublin, Ireland
Codant 30 mg Tablets.
| Pharmaceutical Form |
|---|
|
Tablets. White, circular biconvex tablets of 5.5mm. |
Each tablet contains Codeine Phosphate Hemihydrate 30 mg (equivalent to 23.4 mg Codeine).
Excipient(s) with known effect:
Also contains 43 mg of lactose monohydrate (equivalent to 40.9 mg lactose).
For a full list of excipients, see section 6.1.
| Active Ingredient | Description | |
|---|---|---|
| Codeine |
Codeine is a centrally acting weak analgesic. Codeine exerts its effect through μ opioid receptors, although codeine has low affinity for these receptors, and its analgesic effect is due to its conversion to morphine. Codeine, particularly in combination with other analgesics such as paracetamol, has been shown to be effective in acute nociceptive pain. The anti-tussive activity of codeine is probably due to its depressant effect on the medullary cough centre in the brain. |
| List of Excipients |
|---|
|
Colloidal anhydrous silica |
Polypropylene tablets containers with tamper evident polyethylene caps.
Pack size: 100 tablets.
Mercury Pharmaceuticals (Ireland) Ltd, 4045 Kingswood Road, Citywest Business Park, Co Dublin, Ireland
PA0073/029/001
Date of first authorisation: 1st April 1978
Date of last renewal: 1st April 2008
| Drug | Countries | |
|---|---|---|
| CODANT | Ireland |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
